» Articles » PMID: 16774615

Current Practice of Insulin Pump Therapy in Children and Adolescents - the Hannover Recipe

Overview
Publisher Wiley
Date 2006 Jun 16
PMID 16774615
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing evidence points to the importance of achieving low blood glucose variability and also a low hemoglobin A1c (HbA1c) to prevent diabetic late complications. Continuous subcutaneous insulin infusion (CSII) is associated with lower blood glucose variability in children. Frequent indications for starting CSII in youth are recurrent hypoglycemia, need for increased flexibility, poor glycemic control, dawn phenomenon, or needle phobia. At our center, about one-third of all patients across all age groups are currently on CSII. Although the average glycemic control is not very different from those on multiple daily injections, fewer patients are seen in the segment of very high and very low HbA1c with CSII. Across centers, the 'recipes' tailoring CSII treatment to individual patients and cultures are based more on experience than on evidence. However, several typical pediatric features have been identified. Patterns of the hourly basal rate and prandial insulin requirements vary with age. While many adolescents have increased requirements at dawn and dusk, young children show increasing needs in the second half of the day. Low insulin requirements, particularly in neonates, may need insulin dilution. The selection of catheters and needles has to be appropriate for the age. The opportunity to have an electronic memory read-out of all entries and alarms offers new possibilities of therapeutic monitoring, particularly in those youth not keeping good logbooks. This feature can be helpful, if a trustful relationship between the diabetes team and the family is established.

Citing Articles

Diurnal Variation of Real-Life Insulin Sensitivity Factor Among Children and Adolescents With Type 1 Diabetes Using Ultra-Long-Acting Basal Insulin Analogs.

Hegab A Front Pediatr. 2022; 10:854972.

PMID: 35350271 PMC: 8957904. DOI: 10.3389/fped.2022.854972.


Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.

Alvarenga C, La Banca R, Neris R, Sparapani V, Fuentealba-Torres M, Cartagena-Ramos D BMC Endocr Disord. 2022; 22(1):43.

PMID: 35183150 PMC: 8858488. DOI: 10.1186/s12902-022-00950-7.


100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention.

Ziegler A, Danne T, Daniel C, Bonifacio E Med. 2022; 2(10):1120-1137.

PMID: 34993499 PMC: 8730368. DOI: 10.1016/j.medj.2021.08.003.


Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents.

Demir G, Atik Altinok Y, Ozen S, Darcan S, Goksen D J Clin Res Pediatr Endocrinol. 2020; 13(2):198-203.

PMID: 33374094 PMC: 8186333. DOI: 10.4274/jcrpe.galenos.2020.2020.0171.


Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study.

Mesbah N, Taha N, Rahme Z, Sukkar F, Omar D Med Princ Pract. 2019; 29(3):255-261.

PMID: 31557759 PMC: 7315212. DOI: 10.1159/000503705.